Optimization of rhBMP-2 active-form production in a heterologous expression system using microbiological and molecular genetic approaches


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Recombinant bone morphogenetic protein-2 (rhBMP-2) has pronounced osteoinductive properties, as evidenced by the results of experimental and clinical practices. This applies to both the protein produced in eukaryotic cells and the protein synthesized in bacterial cells. In eukaryotic expression systems, production of the protein is extremely low and, consequently, the cost of materials on its basis is very high. Therefore, optimization of heterologous expression systems for rhBMP-2 production represents an important task. In the present work, optimization of codon composition of the rhBMP-2 gene nucleotide sequence and secondary structure of the transcript, as well as strain selection for efficient gene expression, were carried out. The producing strain based on Escherichia coli BL-21(DE3) provides a high level of rhBMP-2 synthesis (about 57% of total cell proteins). Biological activity of rhBMP-2 dimeric forms purified from the obtained producing strain was measured by induction of alkaline phosphatase activity in C2C12 cells. It is comparable with that of commercial rhBMP-2 expressed in E. coli (R&D Systems, United States). Purified rhBMP-2 does not contain impurities of E. coli endotoxin and can be used in experimental studies of osteoinduction in laboratory animals.

About the authors

A. S. Karyagina

Gamaleya Federal Research Center for Epidemiology and Microbiology; Belozersky Research Institute of Physico-Chemical Biology; All-Russia Research Institute of Agricultural Biotechnology

Author for correspondence.
Email: akaryagina@gmail.com
Russian Federation, Moscow, 123098; Moscow, 119991; Moscow, 127550

I. S. Boksha

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
Russian Federation, Moscow, 123098

T. M. Grunina

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
Russian Federation, Moscow, 123098

A. V. Demidenko

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
Russian Federation, Moscow, 123098

M. S. Poponova

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
Russian Federation, Moscow, 123098

O. V. Sergienko

Gamaleya Federal Research Center for Epidemiology and Microbiology; All-Russia Research Institute of Agricultural Biotechnology

Email: akaryagina@gmail.com
Russian Federation, Moscow, 123098; Moscow, 127550

A. M. Lyaschuk

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
Russian Federation, Moscow, 123098

Z. M. Galushkina

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
Russian Federation, Moscow, 123098

L. A. Soboleva

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
Russian Federation, Moscow, 123098

E. O. Osidak

Gamaleya Federal Research Center for Epidemiology and Microbiology; Imtek Ltd.

Email: akaryagina@gmail.com
Russian Federation, Moscow, 123098; Moscow, 121552

A. S. Semikhin

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
Russian Federation, Moscow, 123098

A. V. Gromov

Gamaleya Federal Research Center for Epidemiology and Microbiology

Email: akaryagina@gmail.com
Russian Federation, Moscow, 123098

V. G. Lunin

Gamaleya Federal Research Center for Epidemiology and Microbiology; All-Russia Research Institute of Agricultural Biotechnology

Email: akaryagina@gmail.com
Russian Federation, Moscow, 123098; Moscow, 127550

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Allerton Press, Inc.